TVTX Earnings

TVTX reported its FY2025Q4 earnings on 2026-02-23, showcasing a revenue of 0.00 against an estimate of 137.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0.04 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following TVTX's FY2025Q4 earnings announcement on 2026-02-23, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, TVTX's stock price tends to shift by an average of -5.86% in the 10 days leading up to earnings and -3.97% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate TVTX’s annual revenue to reach 142.00M, while the EPS is projected at 0.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Upward by 18.89% and EPS estimates Revise Upward by 20.27% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between TVTX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Upward by 18.89%, while EPS estimates moved Revise Upward by 20.27% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TVTX's stock price typically moves by -5.86% in the 10 days before its earnings and -3.97% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 0.00 and revenue of 142.00M.

The earnings call highlights strong financial performance and strategic developments. FILSPARI's growth in IgA nephropathy and potential FSGS approval, along with positive REMS adjustments, suggest a positive outlook. The Q&A reveals consistent demand and effective communication strategies. Despite some management vagueness, the overall sentiment is positive, with expectations of revenue growth and strategic expansions. The market reaction is likely positive, considering these factors.